The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.

@article{Jackson2010TheHP,
  title={The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.},
  author={Christopher G. Jackson and Anna Plaas and John D. Sandy and Crystal Hua and Samantha Kim-Rolands and Jamie G. Barnhill and Crystal L. Harris and Daniel O. Clegg},
  journal={Osteoarthritis and cartilage},
  year={2010},
  volume={18 3},
  pages={
          297-302
        }
}
OBJECTIVE As part of the National Institutes of Health (NIH)-sponsored Glucosamine/Chondroitin sulfate Arthritis Intervention Trial (GAIT) our objective here was to examine (1) the pharmacokinetics (PK) of glucosamine (GlcN) and chondroitin sulfate (CS) when taken separately or in combination as a single dose in normal individuals (n=29) and (2) the PK of GlcN and CS when taken as a single dose after 3 months daily dosing with GlcN, CS or GlcN+CS, in patients with symptomatic knee pain (n=28… Expand
Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties
TLDR
Crystalline glucosamine sulfate 1500 mg once daily is recommended in the majority of clinical practice guidelines and was found to be cost effective in pharmacoeconomic analyses. Expand
Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?
TLDR
All the in vitro and in vivo evidence for the mechanism of action of glucosamine is examined as well as reviews the results of clinical trials and the published recommendations for the management of OA require revision. Expand
Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis
TLDR
This is a large study showing that GS/CS and GH/CS provide clinically meaningful and sustained analgesia in knee OA regardless of dose fractionation and capsule or sachet formulations. Expand
Preclinical Study of the Efficacy and Safety of Chondroitin Sulfate
Chondroitin sulfate is used for osteoarthritis combination therapy. It should be taken into account that the structure and properties of polysaccharides included in chondroitin sulfate, as well asExpand
Absorption and bioavailability of glucosamine in the rat.
TLDR
Glucosamine's low bioavailability is, at least in part, due to its dependence on a transport-facilitated absorption and presystemic loss brought about by the gut microflora. Expand
Subchronic toxicity evaluation of glucosamine and glucosamine in combination with chondroitin sulfate in obese Zucker rats.
TLDR
The studies suggest that the risk of adverse effects of oral D-glucosamine is small compared to that of hyperglycemia in these animals, but the potential for TGFβ1-mediated pathologies, such as osseous metaplasia and renal nephropathy may be increased. Expand
Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment
TLDR
Physician and patient education on the differentiation of pCGS from other glucosamine formulations will help to improve treatment selection, increase treatment adherence, and optimize clinical benefit in OA. Expand
Isotachophoretic determination of glucosamine and chondroitin sulphate in dietary supplements.
Vaclavikova E., Kvasnicka F. (2013): Isotachophoretic determination of glucosamine and chondroitin sulphate in dietary supplements. Czech J. Food Sci., 31: 55–65. Glucosamine and chondroitin sulfate,Expand
Glucosamine dose/concentration-effect correlation in the rat with adjuvant arthritis.
TLDR
GlcN ameliorated and, dose-dependently, prevented AA and controlled nitrite and was inversely correlated with GlcN dose, maximum plasma concentration, and the area under the concentration curve. Expand
Glucosamine for the Treatment of Osteoarthritis: The Time Has Come for Higher-Dose Trials
TLDR
Clinical studies evaluating the dose dependency of glucosamine's influence on osteoarthritis are long overdue, and variations in the patient populations targeted, the assessment vehicles employed, and the potency of glucOSamine preparations tested could be expected to yield some null results. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride.
TLDR
Following oral administration of a clinically recommended dose of glucosamine sulphate (Dona), significantly higher synovial fluid concentrations of glucOSamine are attained, when compared to an equivalent dose of glucose hydrochloride, whether this difference is translated into a therapeutic effect on the joint tissues remains to be elucidated. Expand
Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose.
TLDR
Glucosamine is bioavailable both systemically and at the site of action (the joint) after oral administration of crystalline glucosamine sulphate in ostaeoarthritis patients. Expand
Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses.
TLDR
Clinically relevant dosing of glucosamine HCl in this large monogastric animal model results in serum and synovial fluid concentrations that are at least 500-fold lower than those reported to modify chondrocyte anabolic and catabolic activities in tissue and cell culture experiments. Expand
The effects of oral glucosamine on joint health: is a change in research approach needed?
TLDR
Future research to determine therapeutic mechanisms of GlcN salt preparations will require use of standardized and clinically relevant in vitro assay systems and in vivo animal models for testing, as well as development of new outcome measures for inflammation and pain pathways in human OA. Expand
Characterization of Total Plasma Glycosaminoglycan Levels in Healthy Volunteers Following Oral Administration of a Novel Antithrombotic Odiparcil With Aspirin or Enoxaparin
TLDR
These clinical studies were proof of concept of preclinical rat studies indicating that chronic odiparcil treatment elevates endogenous GAG levels in human subjects. Expand
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
TLDR
Exploratory analyses suggest that the combination of glucosamine and chondroitin sulfate may be effective in the subgroup of patients with moderate-to-severe knee pain, and the efficacy and safety of these treatments as a treatment for knee pain from osteoarthritis are evaluated. Expand
Glucosamine/chondroitin/primorine combination therapy for osteoarthritis.
TLDR
While no studies have evaluated glucosamine sulfate, chondroitin sulfate and primorine in a single product, it may be an option for those who wish to try an alternate therapy for OA, as there appears to be a low risk for serious adverse events. Expand
A physiological function of serum proteoglycan bikunin: The chondroitin sulfate moiety plays a central role
TLDR
The chondroitin sulfate moiety of bikunin is essential for presenting SHAP to hyaluronan, which is indispensable for ovulation and fertilization in mammals. Expand
Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training.
TLDR
Serum COMP decreased significantly over the 12-week training period when treatment with glucosamines was added to the training regimen, suggesting an effect by glucosamine on the response of the OA cartilage to a period of joint loading in humans with knee OA. Expand
A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis.
  • C. T. Vangsness, W. Spiker, Juliana Erickson
  • Medicine
  • Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
  • 2009
TLDR
The excellent safety profile of glucosamine and chondroitin sulfate therapy should be discussed with patients, and these supplements may serve a role as an initial treatment modality for many OA patients. Expand
...
1
2
3
...